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Abstract
Background: Vertical control and elimination programs focused on specific neglected tropical diseases (NTDs) can achieve
notable success by reducing the prevalence and intensity of infection. However, many NTD-endemic countries have not
been able to launch or scale-up programs because they lack the necessary baseline data for planning and advocacy. Each
NTD program has its own mapping guidelines to collect missing data. Where geographic overlap among NTDs exists, an
integrated mapping approach could result in significant resource savings. We developed and field-tested an innovative
integrated NTD mapping protocol (Integrated Threshold Mapping (ITM) Methodology) for lymphatic filariasis (LF), trachoma,
schistosomiasis and soil-transmitted helminths (STH).
Methodology/Principal Findings: The protocol is designed to be resource-efficient, and its specific purpose is to determine
whether a threshold to trigger public health interventions in an implementation unit has been attained. The protocol relies
on World Health Organization (WHO) recommended indicators in the disease-specific age groups. For each disease, the
sampling frame was the district, but for schistosomiasis, the sub-district rather than the ecological zone was used. We tested
the protocol by comparing it to current WHO mapping methodologies for each of the targeted diseases in one district each
in Mali and Senegal. Results were compared in terms of public health intervention, and feasibility, including cost. In this
study, the ITM methodology reached the same conclusions as the WHO methodologies regarding the initiation of public
health interventions for trachoma, LF and STH, but resulted in more targeted intervention recommendations for
schistosomiasis. ITM was practical, feasible and demonstrated an overall cost saving compared with the standard, non-
integrated, WHO methodologies.
Conclusions/Significance: This integrated mapping tool could facilitate the implementation of much-needed programs in
endemic countries.
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Introduction
Neglected tropical diseases (NTDs) are parasitic and bacterial
diseases that affect an estimated 2.7 billion of the world’s poorest
people, causing significant physical debilitation, lowered economic
productivity, and social ostracism for afflicted individuals [1]. Five
NTDs with available preventive chemotherapy: lymphatic filariasis
(LF), trachoma, schistosomiasis, onchocerciasis and the three soil-
transmitted helminths (STH); have been targeted for control or
elimination, but resource constraints in endemic countries have
impeded progress toward these goals [2]. In order to achieve the
rapid scaling-up of programs necessary to reach elimination and
control targets, some by as early as 2020, the global health
community is focusing on developing strategies that capitalize on
synergies between previously independent elimination and control
programs for these diseases. Traditional efforts to treat and
prevent NTDs through vertical programs are often costly, and the
integration of program components has the potential to cut the
costs of NTD programs [3,4].
At the core of public health efforts to fight the five NTDs
mentioned above is a strategy of mass drug administration (MDA)
of at-risk populations with safe and effective drugs often donated
by pharmaceutical companies [5]. Before an MDA can be
launched, a country must demonstrate that the disease threshold
for public health intervention, as established by the World Health
Organization (WHO), has been surpassed [6,7]. The first step in
this process is to review the available data, followed by collecting
missing data by conducting prevalence surveys. Currently, each
NTD program has its own methodology [8]. Conducting multiple
surveys in the same country can be costly and burdensome to
national disease programs. As a result, prevalence surveys are only
conducted when funding has been secured, and data to help
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international partners and program managers with planning and
advocacy, and drug donation programs with drug projections are
unavailable in many parts of sub-Saharan Africa [8]. For this
reason, there is a need for feasible and practical protocols that can
be implemented by Ministries of Health and whose results are
accepted by WHO and drug donation programs. Because NTDs
tend to overlap in geographic areas, it is logical that an integrated
approach to mapping NTDs might result in more efficient
identification of populations needing treatment [9].
This paper describes a novel methodology, the integrated
threshold mapping (ITM) methodology, for an integrated mapping
survey for LF, trachoma, schistosomiasis, and STH. Our
methodology does not provide prevalence figures, its intended
purpose is to determine whether a disease has attained the
threshold for public health intervention by attempting to balance
epidemiologic rigor and field practicality. The ITM protocol has
been field tested in one district in each of two countries by
comparing the ITM methodology to the standard disease-specific
WHO mapping methodologies. Results from both methodologies
were compared in terms of public health intervention based on the
disease specific data and feasibility, including cost.
Materials and Methods
The ITM methodology is derived from rapid mapping
methodologies used by LF and schistosomiasis programs. It is
designed to provide programmatically useful mapping data in a
logistically practical and cost-efficient way.
Study sites
In Mali, the research site included nine sub-districts of the
Banamba district (Koulikoro region), an area with an estimated
population of 88,232 persons (2008). In Senegal, research was
conducted in all 11 non-urban sub-districts of Diourbel district
(Diourbel region), an area with an estimated population of
150,889 persons (2010). In both countries, the majority ethnic
groups, Bambara and Wolof, respectively, are subsistence farmers
living in established settlements; a minority Peuhl group in Mali is
semi-nomadic and engages in cattle herding. The entirety of both
the Banamba and Diourbel districts is located within the
Soudanian ecological zone [10]. NTD program activities
including the provision of preventive chemotherapy for the five
NTDs have been ongoing in Banamba district, but not in
Diourbel district.
Indicators and target age groups
The standard indicators and target age groups currently
recommended by the WHO for the targeted NTDs were
employed for both the ITM and WHO methodologies, although
some minor adaptations were made for trachoma Table 1. For LF,
the immunochromatography card test (ICT, BinaxNOW Filaria-
sis, Alere Inc.), which tests blood drawn by finger stick, was used to
measure the presence of Wuchereria bancrofti antigen in persons aged
$15 years and resident in the village for at least ten years [11].
Results were read after ten minutes and recorded by a trained
laboratory technician. For trachoma, an ophthalmic technician
examined both eyes of children aged 1–9 years for clinical signs of
active trachoma (trachomatous inflammation follicular [TF]) and
of females aged $15 years for clinical signs of trichiasis
(trachomatous trichiasis [TT]) using a binocular loupe and natural
light according to the WHO Simplified Grading System [12]. For
Schistosoma haematobium, the presence of haematuria in urine
samples from children aged 6–9 years was detected by urine
reagent strips. Reagent strips were dipped in the urine samples and
read after one minute by comparing them to a colorimetric scale
by a trained laboratory technician. At the request of the Ministry
of Health (MoH), urine samples were also tested by filtration in
Senegal as part of the WHO methodology [13]. For Schistosoma
mansoni and STH, the prevalence and egg load (eggs per gram of
feces) were calculated using the Kato-Katz method [14].
Integrated Threshold Mapping protocol
Sampling. The sampling, as shown in Figure 1, is a
combination of random and targeted sampling. Although the
protocol is designed for four NTDs, each disease consists of its own
module which can be included in the final mapping protocol,
depending on the NTD(s) that need mapping in a specific area
Figure 2. Two villages per sub-district were selected for trachoma,
STH and schistosomiasis testing. One village was randomly
chosen, and the other was selected based on suspected high S.
haematobium prevalence by the district health officer or local
dispensary staff, according to information on high haematuria
prevalence or the presence of a nearby body of water [15]. When
the random village was the same as the village determined to have
a high likelihood of schistosomiasis, another village was randomly
selected. For LF, only two of the selected villages in the whole
study area were included, with the main selection criterion that
they were 50 kilometers apart [16].
In the village, the team established a testing site at a school or
other central location. A convenience sample of 25 school children
aged 6–9 years was selected to be examined for TF, and 15 of
these children were also asked to give urine and stool samples. An
effort was made to achieve a gender balance. Females aged $15
years were asked to come to the central site with their children
aged 1–5 years. A convenience sample of 50 of these females was
examined for TT, and a convenience sample of 25 children aged
1–5 years was examined for TF, for a total of 50 children tested for
TF in each village. In the two villages where LF was surveyed, a
convenience sample of 100 persons $15 years was tested by ICT.
This normally included the 50 females examined for trachoma as
well as an additional 50 persons. All persons tested for LF had
resided for at least ten years in the village.
Author Summary
Neglected tropical diseases (NTDs) cause significant
physical debilitation, lowered economic productivity, and
social ostracism for afflicted individuals. Five NTDs with
available preventive chemotherapy: lymphatic filariasis
(LF), trachoma, schistosomiasis, onchocerciasis and the
three soil-transmitted helminths (STH); have been targeted
for control or elimination, but resource constraints in
endemic countries have impeded progress toward these
goals. We have developed an integrated mapping
protocol, Integrated Threshold Mapping (ITM) for use by
Ministries of Health to decide where public health
interventions for NTDs are needed. We compared this
protocol to the World Health Organizations disease-
specific mapping protocols in Mali and Senegal. Results
from both methodologies indicated the same public
health interventions for trachoma, LF and STH, while the
ITM methodology resulted in a more targeted intervention
for schistosomiasis. Our study suggests that the integrated
methodology, which is also less expensive and logistically
more feasible to implement, could replace disease-specific
mapping protocols in resource-poor NTD-endemic coun-
tries.
Integrated Mapping for Neglected Tropical Diseases
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Table 1. Indicators, tests, thresholds and interventions recommended by the World Health Organization[6,12].
Disease Indicators Test Threshold for Intervention Public Health Intervention
Trachoma
Trachomatous
Follicular (TF)
Clinical Examination Prevalence of $10% in children aged 1–9 years MDA in total population
Prevalence of 5–9% in children aged 1–9 years Targeted treatment at the sub-district level
Trichiasis (TT) Clinical Examination Prevalence of $1% in adults aged $15 years Surgery program
Schistosomiasis
S. haematobium (S.h) Hematuria Urine dipsticks/filtration Prevalence of S.h and S.m between 10–50% in
children aged 5–14 years
MDA in school-age children every two years
S. mansoni (S.m.) Eggs in stool Kato-Katz Prevalence of S.h and S.m $50% in children
aged 5–14 years
MDA in school-age children and high risk
population
Soil-transmitted
Helminthes
Eggs in stool Kato-Katz Prevalence between 20–50% in children
aged 5–14 years
MDA in school-age children
Prevalence of $50% in children aged 5–14 years MDA twice a year in school-age children
Lymphatic filariasis
Antigen ICT test Prevalence of $1% in adults $15 years MDA in total population
doi:10.1371/journal.pntd.0001380.t001
Figure 1. Diagram showing the sampling methodology for the Integrated Threshold Mapping (ITM) Methodology.
doi:10.1371/journal.pntd.0001380.g001
Integrated Mapping for Neglected Tropical Diseases
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Logistics. An integrated central team of five health workers
from the national level of the MoH conducted the survey. The
team included one laboratory technician for LF, two ophthalmic
technicians for trachoma and two laboratory technicians for
schistosomiasis and STH. Depending on the local situation, the
team engaged health staff from the district laboratory to help
performing Kato-Katz examinations. At the village level, village
chiefs and community health workers were also involved in
registration procedures and other logistics. The central team
received a half-day training on study methodology, sampling, data
collection tools, and the process of obtaining consent and assent.
Because the team members were all active in the national
programs, are engaged in laboratory work on a daily basis and had
been involved in earlier prevalence surveys for these diseases, they
were already trained in their respective diagnostic procedures. The
CDC team supervised all data collection, laboratory preparations
and slide readings for LF, schistosomiasis, and STH to ensure that
all procedures were conducted according to the approved
protocols. For trachoma, all ophthalmic technicians had been
trained in the WHO grading system for trachoma and the
examination of patients for trachoma was also part of their daily
work.
The team traveled together in one vehicle and visited two
villages in one sub-district each day. Specimen collection, point-of-
Figure 2. Some of the possible combinations for the Integrated Threshold Mapping Methodology (ITM).
doi:10.1371/journal.pntd.0001380.g002
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care testing and trachoma examinations were carried out during
the day, and the Kato-Katz was performed each evening. In
Diourbel, the team perfomed the laboratory testing at the district
hospital; in Banamba, the team traveled with all necessary
equipment, including miscroscopes and a generator, and a
laboratory was set up in the dispensary. The CDC personnel
travelling with the team kept records of the time it took to travel to
a village, perform the survey, time taken to prepare and read the
Kato-Katz and urine samples in the laboratory and time to travel
to villages.
WHO protocol
Sampling. For trachoma, the standard WHO 30-cluster
population-based prevalence survey was conducted [12]. Thirty
clusters were selected using probability proportional to estimated
size sampling. Households were selected using an improved EPI
random walk and children aged 1–9 years were examined for TF
and females aged $15 years for TT [17]. Testing continued until
the sample size of 80 children and 50 females per cluster was
reached. When the required sample size in a village was not
attained, the selection continued in an adjacent village. In villages
where examinations had already been conducted using the ITM
methodology, the team examined only an additional 30 children to
avoid examining children twice. For schistosomiasis and STH, the
team randomly selected five villages per ecological zone [15]. The
number of ecological zones in the district was defined by the
national schistosomiasis program coordinator. In each village, the
team established a central testing site and took urine and stool
samples from a convenience sample of 50 children aged 5–14
years. LF was not reassessed because the ITM methodology used
the standard WHO mapping methodology [18].
Logistics. The standard WHO mapping protocols were
conducted by separate teams for schistosomiasis/STH and
trachoma. The teams worked independently. For trachoma, the
number of teams was determined by the standard national
trachoma program practices. In Mali, two trachoma teams, each
composed of two ophthalmic technicians, conducted the trachoma
cluster survey. In Senegal, three teams, each composed of one
ophthalmic technician, conducted the trachoma cluster survey. A
laboratory team, composed of the same two technicians who had
conducted the ITM methodology, implemented the WHO
methodology for schistosomiasis and STH. A half-day training
was provided to all team members on the WHO sampling
methodologies, data collection tools, and the process of obtaining
consent and assent. No diagnostic training was given because the
team members were all active in the national programs as
mentioned above.
The WHO standard methodologies were conducted immedi-
ately following the completion of the integrated methodology.
Each of the three teams traveled in its own vehicle. Testing and
examinations were carried out during the day, and the Kato-Katz
was performed each evening in the district laboratory or in the
dispensary.
Ethical considerations
The study protocol received ethical approval from the Ethics
Committee of the Faculty of Medicine, Pharmacy and Odontol-
ogy-Stomatology, University of Bamako, Bamako, Mali; from the
National Ethics Committee for Health Research (CNERS), Dakar,
Senegal; and from CDC’s Internal Review Board, Atlanta, GA,
USA.
All persons over the age of eighteen years were asked to provide
written consent to participate in the study. The school director or a
member of the team explained the study to the school-aged
children (5–14 years) using a verbal assent script describing the
study, and the children who participated in the study were asked to
give their verbal assent. Written consent to participate in the study
was also obtained from parents or custodians of children between
the ages of 1–18 years.
Children who were found to have active trachoma received two
tubes of tetracycline ointment, to be applied twice daily for a
period of six weeks. Females found to have trichiasis were referred
to the nearest health center that provides trichiasis surgery.
Persons who tested positive for W. bancrofti antigen and children
who were found to be infected with S.haematobium, S.mansoni or
STH were referred to the district health center in case an MDA
was not planned in the district.
Feasibility data
To determine feasibility, we took into consideration time and
resources needed to conduct field activities and overall costs. All
receipts were collected, and actual expenditures were recorded.
The cost data were compiled into four categories: training, per
diems (national and district levels including lodging), travel to the
field (renting of vehicles, drivers and fuel) and supplies (medical
and laboratory). Any costs of inputs that were used for multiple
activities were distributed evenly among the activities. Although
LF testing was only conducted once, costs for conducting the
testing were included for both methodologies. The training of
health personnel on diagnostic methods, salaries and data entry
and analysis conducted by CDC were not included in the cost
analysis.
Data analysis
Results for trachoma, STH and LF were analyzed at the district
level for both methodologies Table 2. Results for schistosomiasis
were calculated at the sub-district level for the ITM methodology
and at the ecological zone level for the WHO methodology. For
the ITM methodology, the results of the two villages per sub-
district were combined, and for the WHO methodology, all
schools were combined. The public health interventions based on
the WHO thresholds Table 1, were compared for both
methodologies. Feasibility, including cost, time and the human
resource needs was compared for both methodologies.
Results
In Banamba District, Mali, 1,898 persons, including 900
children (1–9 years), in 18 villages were surveyed for the ITM
methodology, and 4,479 persons, including 2,738 children (1–9
years) in 35 villages were surveyed for the WHOmethodology. For
trachoma, eight villages already tested for the integrated method
were also sampled for the WHO method. As shown in Figure 3,
the results of both methodologies indicated no need for MDA for
trachoma (ITM Method: 1.9%, WHO method: 4.7%, 95% CI:
2.9–6.5 or STH: 0%, 0%) within the surveyed district. The
methodologies were also concordant in indicating a need for TT
surgeries (ITM Method: 2.6%, WHO Method: 3.7%, 95% CI:
2.4–5.1). The LF mapping was added to validate the feasibility of
the integrated mapping and not to validate the results.
Because the ITM method had as its purpose to refine the
schistosomiasis mapping, the two methods differed, in indicating a
need for schistosomiasis treatment: the WHO methodology
indicated a need for MDA for schistosomiasis among only
school-aged children in the entire area. The ITM methodology
indicated that four sub-districts were in need of MDA for
schistosomiasis among school-aged children only, and that five
sub-districts were in need of MDA for schistosomiasis for the
Integrated Mapping for Neglected Tropical Diseases
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whole population. Treating the whole population in the sub-
districts where this was indicated by the integrated mapping
protocol would result in nearly 33,500 additional at-risk persons
being treated than if only school-aged children in these sub-
districts were treated (as indicated by the WHO protocol).
In Diourbel District, Senegal, 2,734 persons, including 1,100
children (1–9 years), in 22 villages were surveyed for the ITM
methodology, and 4,614 persons, including 2,914 children (1–9
years) in 34 villages for the WHO methodology. For trachoma,
one village already selected for the ITM method was also sampled
for the WHO method. Both methodologies indicated the need for
MDA for trachoma in the surveyed district (ITM Method: 14.9%,
WHO Method: 13.4%, 95% CI: 9.8–17.0) and both methodol-
ogies indicated that there was no need for intervention for STH:
0%, 0%.
Both ITM and WHO methodologies were also concordant
regarding the need for TT surgeries (ITM Method: 4.7%, WHO
Method: 6.1%, 95% CI 4.4–7.7). As mentioned above, the LF
Table 2. Implementation Unit (IU) and sampling frame indicated by WHO guidelines and the Integrated Threshold Mapping
methodology.
WHO ITM
IU for Public Health
intervention Mapping sampling frame
IU for Public Health
intervention
Mapping sampling
frame
Lymphatic filariasis District District District District
Schistosomiasis District/Village Ecological Homogeneous Area Sub-district Sub-district
Soil-transmitted helminths District/Village Ecological Homogeneous Area District District
Trachoma District/Sub-district District District/Sub-district District
doi:10.1371/journal.pntd.0001380.t002
Figure 3. Results from Mali and Senegal from the Integrated Threshold Mapping (ITM) and WHO mapping methodologies.
doi:10.1371/journal.pntd.0001380.g003
Integrated Mapping for Neglected Tropical Diseases
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mapping was added to validate the feasibility of the integrated
mapping and not to validate the results.
In Mali, however, the public health interventions differed with
regards to schistosomiasis treatment because the ITM method had
as its purpose to refine the schistosomiasis mapping. The WHO
methodology indicated a need for MDA for schistosomiasis
treatment among only school-aged children in the entire area,
while the ITM methodology indicated six sub-districts in need of
MDA for schistosomiasis among school-aged children only, four
sub-districts in need of MDA for schistosomiasis for the whole
population and one sub-district which did not pass the threshold
for treatment. Compared to the district based WHO protocol, the
ITM methodology targeted nearly 46,000 extra at-risk individuals
for treatment.
In the ITM methodology, we compared the public health
intervention decisions for schistosomiasis that would result from
using only the randomly or only the targeted selected village
Table 3. Only in nearly half of the sub-districts (5/11 in Senegal;
5/9 in Mali), basing a treatment decision on sampling in a village
considered highly endemic for schistosomiasis would have resulted
in treatment for more persons than if the decision had been based
on sampling in a randomly selected village. The contrary was the
case for 3/11 villages in Senegal and 1/9 villages in Mali.
To compare the feasibility of the two protocols, we compared
the time it took to conduct each survey. For the ITM
methodology, the total number of days on the field was 46
person-days in Mali and 56 persons days in Senegal. It took
approximately two hours to survey one village; in a village where
LF testing was done, four hours were needed. The schistosomiasis
and STH team spent an additional three hours each day preparing
and reading the Kato-Katz slides. The time to travel to the villages
from the health center of the sub-district varied according to
geography from approximately 15 minutes to 1 hour. For the
WHO methodology, the total number of days on the field was 56
person-days for Mali and 58 person-days for Senegal. Each
trachoma team took approximately 4–5 hours to survey one
village. The schistosomiasis and STH team surveyed one village a
day with approximately two hours to collect the samples and an
additional five hours to prepare and read the 50 Kato-Katz and
urine samples in the district laboratory. The time to travel to the
villages varied according to geography from approximately
15 minutes to over 2 hours.
The results of the cost data analysis Table 4, indicate that using
the ITM methodology resulted in a 31% overall cost savings in
Mali ($6,968 vs. $10,039), and a 19% overall cost savings in
Senegal ($8,442 vs. $10,372). In both countries, the ITM
methodology used resources more efficiently than the WHO
methodology in the areas of travel, supplies and team training, as
shown in Table 4.
Discussion
We describe an integrated NTD mapping methodology
(Integrated Threshold Mapping) that can be used as an
operational tool by Ministries of Health in NTD-endemic
countries to determine if the threshold needed to launch disease-
specific public health intervenions has been reached. With the
recent increased interest in NTDs, there is a real need for an
Table 3. Public health interventions for the Integrated Threshold Mapping methodology based on various village selections.
Public health intervention based on village with
suspected high schistosomiasis prevalence
Public health intervention based
on randomly chosen village
Public health intervention
based on the 2 villages combined
Senegal
Ndindy MDA SAC* No MDA MDA SAC
Ngohe MDA total population MDA total population MDA total population
Ndoulo No MDA MDA total population MDA SAC
Thiobe MDA SAC No MDA MDA SAC
Gade Escale MDA SAC No MDA No MDA
Toure Mbonde MDA total population MDA total population MDA total population
Keur Ngalgou MDA SAC MDA total population MDA SAC
Patar MDA total population No MDA MDA SAC
Taiba Moutoupha MDA total population MDA SAC MDA SAC
Tocky Gare MDA SAC MDA total population MDA total population
Danke Sene MDA total population MDA total population MDA total population
Mali
Madina Sacko MDA total population MDA SAC MDA total population
Touba No MDA MDA SAC MDA SAC
Kerouane MDA total population MDA total population MDA total population
Kiban MDA total population MDA SAC MDA total population
Ouleny MDA total population MDA SAC MDA SAC
Toubacoro MDA total population MDA total population MDA total population
Boron MDA SAC MDA SAC MDA SAC
Ouaro MDA total population MDA SAC MDA total population
Guessene MDA total population No MDA MDA SAC
*SAC: school-aged children.
doi:10.1371/journal.pntd.0001380.t003
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integrated mapping approach that can provide district level data in
a timely manner [9,18,19]. In developing this ITM methodology,
we sought to balance epidemiologic rigour with field practicality,
resulting in an approach that can be used only for determining
where public health interventions are needed. With the exception
of some minor modifications for trachoma, we have retained the
key indicators and age groups used in the disease-specific WHO
mapping guidelines, but have adapted the sampling methodolo-
gies. This ITM methodology reduces costs, and the need for
manpower and resources, and gives MoHs a simpler and quicker
way to estimate their NTD needs.
The first step in making a NTD action plan is to evaluate the
existing data, including the methodology and time of the data
collection, and to determine whether any factors that could
influence the prevalence of the disease have changed since the data
were collected. The second step is to collect data where existing
data are missing or out of date; our ITM mapping protocol was
designed for this purpose. Because it will be rare that all four
NTDs will need mapping in any one district, the methodology
consists of disease-specific modules. For each specific situation,
modules can be combined to create the situation-specific NTD
integrated protocol Figure 2.
To understand the value and limitations of this protocol, it is
critical to understand that this protocol is not claiming to provide
epidemiologically correct prevalence data because both the
villages and the individuals tested were not randomly selected.
First, this implies that we cannot recommend using findings from
this methodology as a baseline for measuring impact at the district
level. This is also not possible for the WHO recommended
mapping protocols for schistosomiasis, STH and LF, but it is the
case for the trachoma WHO methodology. A possible second
implication could be that the WHO recommended threshold
could not be used when using this methodology; but here again,
this would only be an issue for trachoma, bearing that the WHO
methodology does not provide epdemiological correct prevalence
figures for schistosomiasis, STH and LF.
One barrier to integrated mapping of NTDs is the misconcep-
tion that mapping can only be integrated if all testing is done using
the same age groups. In our ITM mapping protocol, we insisted
on using the program-specific age groups as indicated by WHO
with the exception of some adaptation for trachoma. The
advantage of using these established age groups was that the
WHO thresholds were applicable and that few people had to
undergo multiple tests and examinations; only in a limited number
of cases were people asked to undergo more than one test or
examination. In each village, we chose to use a convenience
sample for reasons of field practicality. Asking people of different
ages to come to a central location in each village facilitated data
collection and was much more time-efficient than house-to-house
visits, such as those used in the WHO trachoma protocol. As the
field testing in both countries showed, the data of both
methodologies resulted in the same public health recommenda-
tions.
The ITM protocol maintains the WHO-recommended disease
indicators and thresholds for LF, schistosomiasis and STH, but we
used a novel sampling frame for more practical field implemen-
tation. To improve the representativeness for the TF indicator, we
selected a pre-determined number of children between the ages of
1–5 and 6–9. This was intended to prevent biased estimates in case
the 6–9 year age group made up the majority of children being
graded for trachoma because prevalence rates are highest in 1–5
year olds. Although current WHO guidelines measure trichiasis in
adults of both sexes as a standard indicator, literature shows that
different adult age groups have been used to determine TT
prevalence [20,21,22]. After consultation with trachoma experts,
we decided to use women above the age of 15 yrs [22].
Because the ITM methodology is focused on public health
action, the sampling frame is directly linked to the implementation
unit for MDA for each of the NTDs. Based on field experience, we
decided to slightly modify those MDA implementation units to
make public health interventions more feasible in the field, as
shown in Table 2. Because a village-centered approach is difficult
for implementation and supervision for a large-scale national
program, we decided to use the district as the primary
implementation unit for STH as it is recommended by WHO
for LF and trachoma. Our methodology found the same public
health intervention for trachoma and for STH. For STH, both
methodologies concluded that no intervention was necessary,
which confirmed the reliability of our methodology in the two
countries. The LF testing was included to validate only the field
feasibility of integrateing testing for four NTDs. In the case of
schistosomiasis, a disease that is very focal in nature, and for which
treatment medication is costly and in limited supply, we feel that it
would be more appropriate to use the sub-district as implemen-
tation units to determine needs for treatment because a district-
based approach may result in overtreating or undertreating
Table 4. Financial resources used in the Integrated Threshold Mapping (ITM) and WHO methodologies.
Budget Line Items Cost by country and methodology
Mali Senegal
WHO ITM Difference WHO ITM Difference
USD % USD % % USD % USD % %
Training 233 2 167 2 228 596 6 548 6 28
Per diems 2,106 21 1,763 25 216 2,378 23 2,671 32 +12
Travel to the field 4004 40 1796 26 255 3235 31 1519 18 253
Fuel 1,544 752 458 297
Car rental 2,193 933 2,222 978
Driver(s) 267 111 555 244
Supplies 3,696 37 3,242 46 212 4,163 40 3,704 44 211
TOTAL 10,039 6,968 231 10,372 8,442 219
doi:10.1371/journal.pntd.0001380.t004
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subpopulations within the district [23]. Our results show that by
using the sub-district as I.U., the MDA will be more targeted to
people at risk. In our study, when the WHO-recommended
ecological zone was used as the implementation unit, highly
endemic (prevalence of .50%) or low endemic (prevalence of
,10%) sub-areas of the district were not identified, but were
identified by the integrated methodology. As a result, using the
WHO protocol would have meant that tens of thousands of people
living in highly endemic areas would not have received treatment,
and that other people not in need of treatment would have been
treated, as would have been the case in Senegal.
The integrated approach proved to be more efficient in cost,
transport, time in the field and the use of human resources. Because
transportation and per diems are variables that significantly increase
the cost of mapping, we created one small team of experienced
technicians already active in the national MoH program instead of
using multiple disease-specific teams. We decided to limit the
number of team members to five by capitalizing on their laboratory
expertise in parasitic diagnostic techniques mastered during their
lab technician training. Each member of the team performed
multiple tasks, which increased time and energy efficiencies and also
made planning and field organization easier. We also counted on
the strong engagement of local staff as we saw this as capacity
building of district, dispensary, and village health staff. Although the
team members from the different NTD programs were initially
reluctant to work as one team, because it was a new concept, this
hesitancy evaporated over the course of the survey. The team
members also noticed that resources were used more efficiently
compared to the WHOmethodologies: the ITMmethodology used
one vehicle to transport the team, versus 3 used in the WHO
methodologies, employed a 5-member team instead of a 7-member
team, and took about half as much time to implement as the WHO
methodologies.
It is also important to mention that certain cost savings from
integrated mapping such as time saved by only having to plan one
survey compared with several different protocol meetings and
logistic preparations is priceless for overburdened health staff. In
addition, the workload for all the preparations and supervision can
be shared among different program coordinators.
It is worth mentioning that cost savings are just a single variable
that justifies conducting integrated surveys: mapping is often the
first field activity of an integrated NTD program, and the creation
of the team demonstrated the concept of integrating vertical
programs to all levels of the MoH and this first activity can help
with further collaboration for implementing integrated public
health interventions.
Although the ITM methodology resulted in substantial cost
savings compared to the WHO methodology, the cost depends on
the number of sub-units in a district. This means, for example, that
the sampling size for schistosomiasis could be much higher using
the ITM methodology than using the WHO methodology.
However, this would result in a more targeted MDA for
schistosomiasis, which is important because there is limited
availability of donated praziquantel.
The results from both the ITM and WHO methologies indicate
that health workers are not always well-informed about where
schistosomiasis is most prevalent. The results show that treatment
decisions, based on the purposely-selected villages, did not
systematically result in more treatments than those based on the
randomly-selected villages.
We encountered some limitations in conducting the integrated
mapping. We are comparing a convenience sampling for
schistosomiasis and STH mapping with an accepted WHO
convenience sampling. Ideally, we would have compared both
methods to an independent, ‘‘gold standard’’ survey methodology.
The main limitation for the trachoma mapping is that a total of
nine of the 60 trachoma villages sampled were selected for both
methodologies. To decrease the burden of the inhabitants by not
having the same children examined twice, we included the data
collected in the integrated mapping for the WHO method and
added only 30 children by visiting the households. For three
villages, the selection bias was limited because the villages were so
small that the likelihood that all the children in the integrated
method would have also been included by visiting the houses was
very high, but for the other six villages, a selection bias was likely
introduced because up to 62% of the sample was selected by
convenience only and those persons would maybe not have been
included if the sample was collected randomly.
This study shows a novel integrated mapping protocol to
determine whether thresholds for public health interventions have
been reached. The approach is logistically practical, cost-efficient
and flexible. For schistosomiasis, our approach also results in more
targeted MDAs compared with the district level implementation
currently adapted by most integrated NTD program. The protocol
uses mainly the age-specific disease indicators as recommended by
WHO. Further, it sets the stage for all of the following integrated
program activities essential for NTD elimination and control.
Based on the lessons learned from the implementation in the first
two countries and feedback we received form NTD colleagues, we
do recognize that this novel mapping approach requires some
modification to ensure that the most useful data are collected. For
this reason, we are currently field testing an adapted protocol with
all villages selected randomly among other minor changes.
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